tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AU:CYC Stock Latest News

Cyclopharm Raises A$14m Through Institutional Share Placement
Company AnnouncementsCyclopharm Raises A$14m Through Institutional Share Placement
13d ago
CYC
Cyclopharm Seeks ASX Quotation for 9.47 Million New Shares
PremiumCompany Announcements
Cyclopharm Seeks ASX Quotation for 9.47 Million New Shares
13d ago
CYC
Cyclopharm Launches Placement and SPP to Fund Growth
PremiumCompany Announcements
Cyclopharm Launches Placement and SPP to Fund Growth
20d ago
CYC
Cyclopharm Outlines Terms of Confidential Institutional Share Placement
PremiumCompany Announcements
Cyclopharm Outlines Terms of Confidential Institutional Share Placement
20d ago
CYC
Cyclopharm Raises A$14m and Launches A$2m SPP to Accelerate US Technegas Rollout
PremiumCompany Announcements
Cyclopharm Raises A$14m and Launches A$2m SPP to Accelerate US Technegas Rollout
20d ago
CYC
Cyclopharm Posts Record FY2025 Revenue as U.S. Technegas Sales Surge but Loss Widens on Growth Investment
PremiumCompany AnnouncementsCyclopharm Posts Record FY2025 Revenue as U.S. Technegas Sales Surge but Loss Widens on Growth Investment
22d ago
CYC
Cyclopharm Shares Halted Ahead of Capital Raising Announcement
Premium
Company Announcements
Cyclopharm Shares Halted Ahead of Capital Raising Announcement
22d ago
CYC
Cyclopharm Backs AI-Enabled COPD Trial to Expand Reach of Technegas Lung Imaging
Premium
Company Announcements
Cyclopharm Backs AI-Enabled COPD Trial to Expand Reach of Technegas Lung Imaging
26d ago
CYC
Technegas Named Preferred Ventilation Agent in Key US and Global Lung Imaging Guideline
PremiumCompany Announcements
Technegas Named Preferred Ventilation Agent in Key US and Global Lung Imaging Guideline
28d ago
CYC
Cyclopharm Secures Insurer Indemnity in 4DMedical Legal Dispute
PremiumCompany Announcements
Cyclopharm Secures Insurer Indemnity in 4DMedical Legal Dispute
28d ago
CYC
Cyclopharm Secures First U.S. Children’s Hospital Adoption of Technegas
PremiumCompany Announcements
Cyclopharm Secures First U.S. Children’s Hospital Adoption of Technegas
1M ago
CYC
Cyclopharm Wins Colombian Approval for Technegas, Extending Global Lung Imaging Footprint
PremiumCompany Announcements
Cyclopharm Wins Colombian Approval for Technegas, Extending Global Lung Imaging Footprint
2M ago
CYC
Cyclopharm Partners with Western University to Advance Asthma Detection
PremiumCompany AnnouncementsCyclopharm Partners with Western University to Advance Asthma Detection
3M ago
CYC
Cyclopharm Sells Cyclotron Asset to Focus on Technegas® Expansion
Premium
Company Announcements
Cyclopharm Sells Cyclotron Asset to Focus on Technegas® Expansion
3M ago
CYC
Cyclopharm Limited to Host Webinar on 1H 2025 Results and Future Prospects
Premium
Company Announcements
Cyclopharm Limited to Host Webinar on 1H 2025 Results and Future Prospects
6M ago
CYC
Cyclopharm Achieves Record Revenue and Expands U.S. Market Presence
PremiumCompany Announcements
Cyclopharm Achieves Record Revenue and Expands U.S. Market Presence
6M ago
CYC
Cyclopharm Limited Reports Revenue Growth Amid Increased Losses
PremiumCompany Announcements
Cyclopharm Limited Reports Revenue Growth Amid Increased Losses
6M ago
CYC
Cyclopharm Strengthens U.S. Sales Strategy with Key Appointment
PremiumCompany Announcements
Cyclopharm Strengthens U.S. Sales Strategy with Key Appointment
7M ago
CYC
Cyclopharm Secures U.S. Patent Extension for Technegas® to 2031
PremiumCompany Announcements
Cyclopharm Secures U.S. Patent Extension for Technegas® to 2031
9M ago
CYC
Cyclopharm Limited Secures Shareholder Approval for Key Resolutions at AGM
PremiumCompany AnnouncementsCyclopharm Limited Secures Shareholder Approval for Key Resolutions at AGM
9M ago
CYC
Cyclopharm Limited Releases Cautious Financial Projections
Premium
Company Announcements
Cyclopharm Limited Releases Cautious Financial Projections
9M ago
CYC
Cyclopharm Achieves Record Sales with US Expansion in 2024
Premium
Company Announcements
Cyclopharm Achieves Record Sales with US Expansion in 2024
9M ago
CYC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >